BREATIV Trademark

Trademark Overview


On Friday, May 5, 2017, a trademark application was filed for BREATIV with the United States Patent and Trademark Office. The USPTO has given the BREATIV trademark a serial number of 87438529. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Wednesday, June 5, 2024. This trademark is owned by Glaxo Group Limited. The BREATIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
breativ

General Information


Serial Number87438529
Word MarkBREATIV
Filing DateFriday, May 5, 2017
Status710 - CANCELLED - SECTION 8
Status DateWednesday, June 5, 2024
Registration Number5340655
Registration DateTuesday, November 21, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateWednesday, June 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Wednesday, July 19, 2017ASSIGNED TO EXAMINER
Wednesday, July 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 5, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2017REGISTERED-PRINCIPAL REGISTER
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2017NEW APPLICATION ENTERED
Thursday, May 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 16, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 21, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 5, 2024CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED